Clinical trials, aimed at testing more than 700 patients infected with the Wuhan coronavirus, have succeeded in recruiting fewer than 200 people after 10 days
Scientists racing to find a vaccine for the Wuhan coronavirus are hoping a cutting-edge approach called “rapid response platforms” will quickly yield a breakthrough. WSJ’s Jason Bellini explains what these are and how they work. Photo: Tolga Akmen / AFPBEIJING—Clinical trials being conducted in Wuhan to test Gilead Sciences Inc.
The trials, aimed at testing more than 700 patients infected with the Wuhan coronavirus, have succeeded in recruiting fewer than 200 people after 10 days.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead’s Coronavirus Drug Trial Slowed Due to Lack of Eligible RecruitsClinical trials being conducted in Wuhan to test Gilead Sciences Inc.’s antiviral drug, a promising remedy for the new coronavirus, are going more slowly than hoped for as the drugmaker struggles to recruit qualified patients, underscoring the challenges in quickly developing drugs during outbreaks.
Read more »
Japan to start trials using HIV treatment for coronavirus: SugaJapan is aiming to start trials soon using an HIV treatment for the coronavirus,...
Read more »
Japan to start trials using HIV treatment for coronavirus - SugaJapan is aiming to start trials soon using an HIV treatment for the coronavirus,...
Read more »
Japan plans HIV drug trials for coronavirus, cruise ship evacuations continueJapan plans HIV drug trials for coronavirus, cruise ship evacuations continue by sakmurakami juminism For the latest developments around the new coronavirus outbreak, follow our liveblog:
Read more »
Coronavirus slows China's Belt and Road pushWhen President Xi Jinping made his first state visit this year to Myanmar and si...
Read more »
Coronavirus infections slow in China as Apple warns of iPhone shortagesThe number of new coronavirus infections in mainland China fell below 2,000 on T...
Read more »